Roles of Genetic Variants in the PI3K and RAS/RAF Pathways in Susceptibility to Endometrial Cancer and Clinical Outcomes

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2011 Dec 8

PMID 22146979

Citations 30

Authors

Li-E Wang

Hongxia Ma

Katherine S Hale

Ming Yin

Larissa A Meyer

Hongliang Liu

Jie Li

Karen H Lu

Bryan T Hennessy

Xuesong Li

Margaret R Spitz

Qingyi Wei

Gordon B Mills

Affiliations

Soon will be listed here.

Abstract

Purpose: The phosphatidylinositol 3-kinase (PI3K)/PTEN/AKT/mTOR and Ras/Raf/MEK/ERK pathways have been implicated in endometrial tumorigenesis. In this candidate pathway analysis, we investigated associations between genetic variations in these two pathways and both risk and clinical outcomes of endometrial cancer.

Methods: We genotyped a total of 48 potentially functional SNPs in 11 key genes (AKT1, AKT2, AKT3, BRAF, FRAP1, KRAS, PDPK1, PIK3CA, PIK3CB, PIK3R1, and PTEN) with the Sequenom genotyping platform in 115 endometrial cancer patients and 230 cancer-free women to evaluate their associations with risk, survival, and recurrence of endometrial cancer.

Results: We found the following: (1) PIK3CA rs6443624 and rs9838411 variants either borderline or significantly decreased risk of endometrial cancer in a dominant model (adjusted odds ratio [OR], 0.62; 95% CI, 0.39-1.00 and 0.59; 95% CI, 0.36-0.95, respectively). Furthermore, there was a statistically significant multiplicative interaction (P (int) = 0.036) between these two loci in risk of endometrial cancer. In contrast, the AKT1 rs2498801 genotype significantly increased risk of endometrial cancer (adjusted OR, 1.94; 95% CI, 1.02-3.67 in a recessive model). (2) In Cox regression analyses, three SNPs (PIK3R1 rs1862162, AKT2 rs892119, and PIK3CA rs2699887) showed significant associations with survival of endometrial cancer patients. (3) KRAS rs7312175 and PIK3CA rs6443624 had significant effects on recurrence of endometrial cancer individually and combined in a locus-dosage manner (adjusted P (trend) = 0.003).

Conclusion: These results suggest that common genetic variations in these pathways may modulate risk and clinical outcomes of endometrial cancer. Further replication and functional studies are needed to confirm these findings.

Citing Articles

Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response.

Hu Z, Wu Z, Liu W, Ning Y, Liu J, Ding W Nat Genet. 2024; 56(4):637-651.

PMID: 38565644 DOI: 10.1038/s41588-024-01703-z.

mTOR pathway candidate genes and obesity interaction on breast cancer risk in black women from the Women's Circle of Health Study.

Ilozumba M, Yaghjyan L, Datta S, Zhao J, Hong C, Lunetta K Cancer Causes Control. 2023; 34(5):431-447.

PMID: 36790512 PMC: 10695180. DOI: 10.1007/s10552-022-01657-9.

Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant.

Correia L, Magno R, Xavier J, de Almeida B, Duarte I, Esteves F NPJ Breast Cancer. 2022; 8(1):71.

PMID: 35676284 PMC: 9177727. DOI: 10.1038/s41523-022-00435-9.

Biomolecular and Genetic Prognostic Factors That Can Facilitate Fertility-Sparing Treatment (FST) Decision Making in Early Stage Endometrial Cancer (ES-EC): A Systematic Review.

Tanos P, Dimitriou S, Gullo G, Tanos V Int J Mol Sci. 2022; 23(5).

PMID: 35269800 PMC: 8910305. DOI: 10.3390/ijms23052653.

Polymorphisms in the mTOR-PI3K-Akt pathway, energy balance-related exposures and colorectal cancer risk in the Netherlands Cohort Study.

Simons C, Schouten L, Godschalk R, van Schooten F, Stoll M, Van Steen K BioData Min. 2022; 15(1):2.

PMID: 35012583 PMC: 8751328. DOI: 10.1186/s13040-021-00286-3.

References

Antico-Arciuch V, Dima M, Liao X, Refetoff S, Di Cristofano A . Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females. Oncogene. 2010; 29(42):5678-86. PMC: 2967724. DOI: 10.1038/onc.2010.308. View

Wang T, Ho G, Ye K, Strickler H, Elston R . A partial least-square approach for modeling gene-gene and gene-environment interactions when multiple markers are genotyped. Genet Epidemiol. 2008; 33(1):6-15. PMC: 2700837. DOI: 10.1002/gepi.20351. View

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang S . PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997; 275(5308):1943-7. DOI: 10.1126/science.275.5308.1943. View

Li L, Plummer S, Thompson C, Tucker T, Casey G . Association between phosphatidylinositol 3-kinase regulatory subunit p85alpha Met326Ile genetic polymorphism and colon cancer risk. Clin Cancer Res. 2008; 14(3):633-7. DOI: 10.1158/1078-0432.CCR-07-1211. View

Yuan T, Cantley L . PI3K pathway alterations in cancer: variations on a theme. Oncogene. 2008; 27(41):5497-510. PMC: 3398461. DOI: 10.1038/onc.2008.245. View

Quaye L, Song H, Ramus S, Gentry-Maharaj A, Hogdall E, DiCioccio R . Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer. 2009; 100(6):993-1001. PMC: 2661781. DOI: 10.1038/sj.bjc.6604947. View

Murayama-Hosokawa S, Oda K, Nakagawa S, Ishikawa S, Yamamoto S, Shoji K . Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway. Oncogene. 2010; 29(13):1897-908. DOI: 10.1038/onc.2009.474. View

Lacey Jr J, Yang H, Gaudet M, Dunning A, Lissowska J, Sherman M . Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol. 2010; 120(2):167-73. PMC: 3073848. DOI: 10.1016/j.ygyno.2010.10.016. View

Carpten J, Faber A, Horn C, Donoho G, Briggs S, Robbins C . A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature. 2007; 448(7152):439-44. DOI: 10.1038/nature05933. View

10.

Chen J, Wang Q, Fu X, Huang X, Chen X, Cao L . Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9. Hepatol Res. 2009; 39(2):177-86. DOI: 10.1111/j.1872-034X.2008.00449.x. View

11.

Philp A, Campbell I, Leet C, Vincan E, Rockman S, Whitehead R . The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res. 2001; 61(20):7426-9. View

12.

Lax S . Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium. Pathology. 2007; 39(1):46-54. DOI: 10.1080/00313020601146822. View

13.

Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011; 61(4):212-36. DOI: 10.3322/caac.20121. View

14.

Ninomiya Y, Kato K, Takahashi A, Ueoka Y, Kamikihara T, Arima T . K-Ras and H-Ras activation promote distinct consequences on endometrial cell survival. Cancer Res. 2004; 64(8):2759-65. DOI: 10.1158/0008-5472.can-3487-2. View

15.

Steelman L, Stadelman K, Chappell W, Horn S, Basecke J, Cervello M . Akt as a therapeutic target in cancer. Expert Opin Ther Targets. 2008; 12(9):1139-65. DOI: 10.1517/14728222.12.9.1139. View

16.

Catasus L, Gallardo A, Cuatrecasas M, Prat J . PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters. Mod Pathol. 2007; 21(2):131-9. DOI: 10.1038/modpathol.3800992. View

17.

Luo J, Cantley L . The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer. Cell Cycle. 2005; 4(10):1309-12. DOI: 10.4161/cc.4.10.2062. View

18.

Mizuuchi H, Nasim S, Kudo R, Silverberg S, Greenhouse S, Garrett C . Clinical implications of K-ras mutations in malignant epithelial tumors of the endometrium. Cancer Res. 1992; 52(10):2777-81. View

19.

Minaguchi T, Yoshikawa H, Oda K, Ishino T, Yasugi T, Onda T . PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin Cancer Res. 2001; 7(9):2636-42. View

20.

Treloar S, Zhao Z, Le L, Zondervan K, Martin N, Kennedy S . Variants in EMX2 and PTEN do not contribute to risk of endometriosis. Mol Hum Reprod. 2007; 13(8):587-94. DOI: 10.1093/molehr/gam023. View